# Irinotecan

## Irino IV infusion 100mg/5mL

| TAH Drug Code      | [IIRI](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IIRI)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | First-line treatment for advanced colorectal cancer: - In combination with 5-FU and folinic acid， used in patients who have not previously received chemotherapy. - Used alone in patients who have not responded to 5-FU treatment. - In combination with cetuximab， for the treatment of metastatic colorectal cancer patients who have failed irinotecan-based chemotherapy and have epidermal growth factor receptor (EGFR) positive KRAS wild-type tumors. - In combination with 5-fluorouracil， folinic acid， and bevacizumab， as a first-line treatment for metastatic colorectal or rectal cancer. - In combination with capecitabine， as a first-line treatment for metastatic colorectal cancer. - In combination with 5-fluorouracil， leucovorin， and oxaliplatin (FOLFIRINOX)， as a first-line treatment for metastatic pancreatic cancer. - As a treatment for locally advanced， unresectable， and recurrent/metastatic gastric cancer. |
| Dosing             | Monotherapy (for previously treated patient): [Colorectal cancer， metastatic] 350 mg/m2 as a single agent infused over 90 minutes once every 3 weeks. [Gastric cancer， metastatic or locally advanced] 150 mg/m2 as a single agent infused over 30-90 minutes on days 1 and 15 of a 4-week treatment cycle. Combination therapy (for treatment naive patients):180 mg/m2 over 90 minutes on days 1， 15， and 29 in combination with infusional leucovorin and bolus/infusion fluorouracil (leucovorin administered immediately following irinotecan; fluorouracil immediately following leucovorin).                                                                                                                                                                                                                                                                                                                                                         |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Contraindications  | Known hypersensitivity to irinotecan or any component of the formulation. Coadministraton with azole antifungals (ketoconazole， fluconazole， itraconazole); patients with hereditary fructose intolerance                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Adverse Effects    | Neutropenia， anemia， thrombocytopenia; acute diarrhoea， sweating， hypersalivation， abdominal cramps， lachrymation， miosis， weakness; nausea， vomiting， alopecia and skin reactions; cardiovascular toxicity. Potentially Fatal: Fatal sepsis due to myelosuppression; severe， chronic diarrhoea                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| More Info          | [UpToDate](https://www.uptodate.com/contents/irinotecan-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |

